Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

417 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lung Cancer in Hungary.
Bogos K, Kiss Z, Gálffy G, Tamási L, Ostoros G, Müller V, Urbán L, Bittner N, Sárosi V, Vastag A, Polányi Z, Nagy-Erdei Z, Vokó Z, Nagy B, Horváth K, Rokszin G, Abonyi-Tóth Z, Barcza Z, Moldvay J. Bogos K, et al. Among authors: urban l. J Thorac Oncol. 2020 May;15(5):692-699. doi: 10.1016/j.jtho.2019.11.001. J Thorac Oncol. 2020. PMID: 32340676 Free article. No abstract available.
[Novel approaches to the epidemiology of lung cancer in Hungary].
Bogos K, Kiss Z, Gálffy G, Tamási L, Ostoros G, Müller V, Urbán L, Bittner N, Sárosi V, Vastag A, Polányi Z, Nagy-Erdei Z, Vokó Z, Nagy B, Rokszin G, Abonyi-Tóth Z, Moldvay J. Bogos K, et al. Among authors: urban l. Magy Onkol. 2020 Sep 23;64(3):175-181. Epub 2020 Sep 14. Magy Onkol. 2020. PMID: 32966347 Free article. Hungarian.
Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016.
Tamási L, Horváth K, Kiss Z, Bogos K, Ostoros G, Müller V, Urbán L, Bittner N, Sárosi V, Vastag A, Polányi Z, Nagy-Erdei Z, Daniel A, Nagy B, Rokszin G, Abonyi-Tóth Z, Moldvay J, Vokó Z, Gálffy G. Tamási L, et al. Among authors: urban l. Pathol Oncol Res. 2021 Apr 30;27:598862. doi: 10.3389/pore.2021.598862. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34257553 Free PMC article.
Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011-2016.
Bogos K, Kiss Z, Tamási L, Ostoros G, Müller V, Urbán L, Bittner N, Sárosi V, Vastag A, Polányi Z, Nagy-Erdei Z, Daniel A, Vokó Z, Nagy B, Horváth K, Rokszin G, Abonyi-Tóth Z, Barcza Z, Gálffy G, Moldvay J. Bogos K, et al. Among authors: urban l. Pathol Oncol Res. 2021 Apr 30;27:603937. doi: 10.3389/pore.2021.603937. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34257563 Free PMC article.
Significant Regional Differences in Lung Cancer Incidence in Hungary: Epidemiological Study Between 2011 and 2016.
Gálffy G, Vastag A, Bogos K, Kiss Z, Ostoros G, Müller V, Urbán L, Bittner N, Sárosi V, Polányi Z, Nagy-Erdei Z, Daniel A, Knollmajer K, Várnai M, Szegner P, Vokó Z, Nagy B, Horváth K, Rokszin G, Abonyi-Tóth Z, Pozsgai É, Barcza Z, Moldvay J, Tamási L. Gálffy G, et al. Among authors: urban l. Pathol Oncol Res. 2021 Sep 14;27:1609916. doi: 10.3389/pore.2021.1609916. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34594159 Free PMC article.
Increase in the Length of Lung Cancer Patient Pathway Before First-Line Therapy: A 6-Year Nationwide Analysis From Hungary.
Kiss Z, Bogos K, Tamási L, Ostoros G, Müller V, Urbán L, Bittner N, Sárosi V, Vastag A, Polányi Z, Nagy-Erdei Z, Knollmajer K, Várnai M, Nagy B, Horváth K, Rokszin G, Abonyi-Tóth Z, Barcza Z, Moldvay J, Gálffy G, Vokó Z. Kiss Z, et al. Among authors: urban l. Pathol Oncol Res. 2021 Dec 23;27:1610041. doi: 10.3389/pore.2021.1610041. eCollection 2021. Pathol Oncol Res. 2021. PMID: 35002544 Free PMC article.
Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary.
Bogos K, Kiss Z, Gálffy G, Tamási L, Ostoros G, Müller V, Urbán L, Bittner N, Sárosi V, Vastag A, Polányi Z, Nagy-Erdei Z, Vokó Z, Nagy B, Horváth K, Rokszin G, Abonyi-Tóth Z, Moldvay J. Bogos K, et al. Among authors: urban l. Front Oncol. 2019 Oct 23;9:1051. doi: 10.3389/fonc.2019.01051. eCollection 2019. Front Oncol. 2019. PMID: 31709174 Free PMC article.
Smoking History Predicts Sensitivity to PARP Inhibitor Veliparib in Patients with Advanced Non-Small Cell Lung Cancer.
Reck M, Blais N, Juhasz E, Gorbunova V, Jones CM, Urban L, Orlov S, Barlesi F, Kio E, Keilholz U, Qin Q, Qian J, Nickner C, Dziubinski J, Xiong H, Mittapalli RK, Dunbar M, Ansell P, He L, McKee M, Giranda V, Ramalingam SS. Reck M, et al. Among authors: urban l. J Thorac Oncol. 2017 Jul;12(7):1098-1108. doi: 10.1016/j.jtho.2017.04.010. Epub 2017 Apr 29. J Thorac Oncol. 2017. PMID: 28461256 Free article. Clinical Trial.
Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement.
Schwab R, Petak I, Kollar M, Pinter F, Varkondi E, Kohanka A, Barti-Juhasz H, Schönleber J, Brauswetter D, Kopper L, Urban L. Schwab R, et al. Among authors: urban l. Lung Cancer. 2014 Jan;83(1):109-11. doi: 10.1016/j.lungcan.2013.10.006. Epub 2013 Oct 19. Lung Cancer. 2014. PMID: 24192513
Randomized, Placebo-Controlled, Phase II Study of Veliparib in Combination with Carboplatin and Paclitaxel for Advanced/Metastatic Non-Small Cell Lung Cancer.
Ramalingam SS, Blais N, Mazieres J, Reck M, Jones CM, Juhasz E, Urban L, Orlov S, Barlesi F, Kio E, Keiholz U, Qin Q, Qian J, Nickner C, Dziubinski J, Xiong H, Ansell P, McKee M, Giranda V, Gorbunova V. Ramalingam SS, et al. Among authors: urban l. Clin Cancer Res. 2017 Apr 15;23(8):1937-1944. doi: 10.1158/1078-0432.CCR-15-3069. Epub 2016 Oct 10. Clin Cancer Res. 2017. PMID: 27803064 Clinical Trial.
417 results